Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.

French report on improving access to drug information published

Eveline Van Keymeulen

The French Minister of Healthcare recently announced the publication of a report  on improving access for patients and healthcare professionals to information on medicinal products. The report includes, in particular, recommendations on how to improve the information content (targets, quality, verification and so on) and evolution (especially during a health crisis), as well as access Read More

Telemedicine becomes a reality in France

Eveline Van Keymeulen

In September 2018, French Decree 2018-788, which sets out the conditions to provide telemedicine acts, entered into force. The Decree was adopted pursuant to Article 54 of the 2018 Social Security Financing Bill. It exempts health care professionals conducting a medical follow-up of patients over long distances (tele-monitoring) from obtaining, as required by Article R. 161-43 of the Read More

Dutch authorities to investigate possible inducement payments in medical devices sector

Iradj Nazaryar

The Dutch Health and Youth Inspectorate (HYI) has announced plans to investigate possible inducement payments in the medical devices sector. The investigation, which will start in the autumn of 2018, will focus on cardiology, orthopaedics and dental implants by looking into the service contract meetings that suppliers may have concluded with healthcare professionals. Moreover, suppliers Read More

French ATU procedure simplified to ensure rapid patient access to innovations

Eveline Van Keymeulen

On 17 September 2018, the National Agency for Medicines and Health Products Safety (ANSM) introduced  a single portal for health care professionals to apply for individual temporary authorisations for use (ATUs) with the aim of increasing transparency and simplifying the processing of ATU applications to ensure earlier management of patients likely to benefit from new Read More

Belgian report shows limited success in screening of health insurance funds

Veerle Pissierssens

A recent report from the Belgian Court of Audit reportedly shows that the information that health insurance funds must disclose pursuant to the requirements set in the 2016 “Future Pact” (Toekomstpact), which mainly pertain to internal inspections and accountancy, is too fragmented and therefore of little use. The report also recommends granting inspection services access to Read More